Modeling Pharmacodynamic Biomarkers related to CDK4/6 Inhibition and Cell Cycle Modulation in Patients with Advanced Breast Cancer

被引：0
|
作者：
Sun, Wan [1 ]
Liu, Yuan [1 ]
Wang, Diane [1 ]
机构：
[1] Pfizer, Clin Pharmacol, San Diego, CA USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-042
引用
收藏
页码：S22 / S23
页数：2
相关论文
共 50 条
  • [1] Pharmacodynamic Modeling of CDK4/6 Inhibition-Related Biomarkers and the Characterization of the Relationship Between Biomarker Response and Progression-Free Survival in Patients With Advanced Breast Cancer
    Yu, Yanke
    Sun, Wan
    Liu, Yuan
    Wang, Diane
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (03): : 376 - 384
  • [2] Modeling of pharmacodynamic (PD) biomarkers (BM) related to CDK4/6 inhibition and exploratory BM-response (progression free survival [PFS]) analyses in patients with advanced breast cancer.
    Yu, Yanke
    Liu, Yuan
    Wang, Diane Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
    Goel, Shom
    DeCristo, Molly J.
    McAllister, Sandra S.
    Zhao, Jean J.
    TRENDS IN CELL BIOLOGY, 2018, 28 (11) : 911 - 925
  • [4] CDK4/6 inhibition in cancer: the cell cycle splicing connection
    Sheppard, Karen E.
    AbuHammad, Shatha
    MOLECULAR & CELLULAR ONCOLOGY, 2019, 6 (06)
  • [5] Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
    Piezzo, Michela
    Cocco, Stefania
    Caputo, Roberta
    Cianniello, Daniela
    Di Gioia, Germira
    Di Lauro, Vincenzo
    Fusco, Giuseppina
    Martinelli, Claudia
    Nuzzo, Francesco
    Pensabene, Matilde
    De Laurentiis, Michelino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 23
  • [6] CDK4/6 INHIBITION IN BREAST CANCER: THE LATE HARVEST CYCLE BEGINS
    Goel, Shom
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 96 - 96
  • [7] Use of Pharmacokinetic and Pharmacodynamic Data to Develop the CDK4/6 Inhibitor Ribociclib for Patients with Advanced Breast Cancer
    Ji, Yan
    Schiller, Hilmar
    Yang, Shu
    Quinlan, Michelle
    Darstein, Christelle
    Huth, Felix
    Winter, Serge
    Chakraborty, Abhijit
    CLINICAL PHARMACOKINETICS, 2024, 63 (02) : 155 - 170
  • [8] The Role of CDK4/6 Inhibition in Breast Cancer
    Murphy, Conleth G.
    Dickler, Maura N.
    ONCOLOGIST, 2015, 20 (05): : 483 - U49
  • [9] CDK4/6 inhibition in luminal breast cancer
    Gampenrieder S.P.
    Rinnerthaler G.
    Greil R.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 76 - 81
  • [10] Use of Pharmacokinetic and Pharmacodynamic Data to Develop the CDK4/6 Inhibitor Ribociclib for Patients with Advanced Breast Cancer
    Yan Ji
    Hilmar Schiller
    Shu Yang
    Michelle Quinlan
    Christelle Darstein
    Felix Huth
    Serge Winter
    Abhijit Chakraborty
    Clinical Pharmacokinetics, 2024, 63 : 155 - 170
12345